A862 15 mg Pill - yellow & white capsule-shape
Pill with imprint A862 15 mg is Yellow & White, Capsule-shape and has been identified as Methylphenidate Hydrochloride Extended-Release 15 mg. It is supplied by Actavis Pharma, Inc.
Methylphenidate is used in the treatment of ADHD; Narcolepsy; Depression and belongs to the drug class CNS stimulants. Risk cannot be ruled out during pregnancy. Methylphenidate 15 mg is classified as a Schedule 2 controlled substance under the Controlled Substance Act (CSA).
Images for A862 15 mg
Methylphenidate Hydrochloride Extended-Release
- Imprint
- A862 15 mg
- Strength
- 15 mg
- Color
- Yellow & White
- Shape
- Capsule-shape
- Availability
- Prescription only
- Drug Class
- CNS stimulants
- Pregnancy Category
- C - Risk cannot be ruled out
- CSA Schedule
- 2 - High potential for abuse
- Labeler / Supplier
- Actavis Pharma, Inc.
- National Drug Code (NDC)
- 00591-3862
More about methylphenidate
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (1,038)
- Drug images
- Latest FDA alerts (4)
- Side effects
- Dosage information
- Patient tips
- During pregnancy
- Support group
- Drug class: CNS stimulants
- Breastfeeding
Patient resources
- Methylphenidate drug information
- Methylphenidate transdermal
- Methylphenidate (Oral) (Advanced Reading)
- Methylphenidate (Transdermal) (Advanced Reading)
- Methylphenidate Controlled-Release Tablets
Other brands
Ritalin, Concerta, Ritalin LA, Jornay PM, ... +11 more
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.